Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Bea parkir digabung ke pajak STNK: Praktis tapi berisiko merugikan

● Pemerintah sempat mewacanakan pajak STNK digabung dengan biaya parkir setahun.● Tarif yang ditawarkan tergolong murah, mulai dari Rp2 ribu per hari.● Tanpa persiapan yang baik, wac...

Trik ‘marketing’ jitu Denny Caknan meneruskan Didi Kempot memopulerkan musik Jawa

● Stigma musik Jawa yang dulu dikenal “katrok” agaknya sudah berubah.● Ketika legenda musik Jawa Didi Kempot berpulang, banyak yang memprediksi takkan ada regenerasi.● Po...

Menelusuri jejak pesut, mamalia air penjaga wilayah pesisir Riau

Pernah dengar tentang pesut yang dikenal dengan nama ilmiah Orcaella brevirostris?Spesies ini kini menjadi perhatian serius para konservasionis karena sudah berstatus terancam punah, lokasi keberadaan...